CVE-2021-44916

Public Exploit

Description

Opmantek Open-AudIT Community 4.2.0 (Fixed in 4.3.0) is affected by a Cross Site Scripting (XSS) vulnerability. If a bad value is passed to the routine via a URL, malicious JavaScript code can be executed in the victim's browser.

Category

6.1
CVSS
Severity: Medium
CVSS 3.1 •
CVSS 2.0 •
EPSS 4.46% Top 15%
Vendor Advisory opmantek.com Vendor Advisory opmantek.com
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
https://community.opmantek.com/display/OA/Errata+-+4.2.0+and+earlier+Javascript+vulnerability patch vendor advisory mitigation
https://community.opmantek.com/display/OA/Release+Notes+for+Open-AudIT+v4.3.0 release notes vendor advisory
https://github.com/Opmantek/open-audit/commit/e37b64bbd0219f03cb71cc1cd5bb010166a2b846 third party advisory patch
http://packetstormsecurity.com/files/165502/Open-AudIT-Community-4.2.0-Cross-Site-Scripting.html exploit vdb entry third party advisory

Frequently Asked Questions

What is the severity of CVE-2021-44916?
CVE-2021-44916 has been scored as a medium severity vulnerability.
How to fix CVE-2021-44916?
To fix CVE-2021-44916, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2021-44916 being actively exploited in the wild?
It is possible that CVE-2021-44916 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~4% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.